Juniper Pharmaceuticals, Inc., a diversified healthcare company focused on women’s health, announced Wednesday that it is exploring strategic alternatives “in order to enhance shareholder value.” The company has engaged Rothschild as its independent financial advisor to assist Juniper and its board in evaluating potential strategic alternatives. “Over the past year, we have made important investments into our core…

Juniper Pharmaceuticals announces 4.5-year extension through 2024 of Crinone supply agreement with Merck KGaA, Darmstadt, Germany. Juniper Pharmaceuticals  a diversified healthcare company focused on women’s health, announced the extension of its supply agreement for Crinone (progesterone gel) with an affiliate of Merck KGaA, Darmstadt, Germany. The amended agreement extends the supply term an additional 4.5 years and at…